| 6-OHDA | 6-Hydroxydopamine |
| ABTS | 2,2-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid |
| ACE | Angiotensin-Converting Enzyme |
| AChE | Acetylcholinesterase |
| ALP | Alkaline Phosphatase |
| ALT | Alanine Aminotransferase |
| AST | Aspartate Aminotransferase |
| Aβ | Amyloid-beta |
| BChE | Butyrylcholinesterase |
| CAT | Catalase |
| CCl4 | Carbon Tetrachloride |
| CDC2 | Cell Division Cycle 2 kinase |
| CDK4 | Cyclin-Dependent Kinase 4 |
| COX-1 | Cyclooxygenase-1 |
| COX-2 | Cyclooxygenase-2 |
| CUPRAC | Cupric Reducing Antioxidant Capacity |
| DMBA | 7,12-Dimethylbenz[a]anthracene |
| DPP-IV | Dipeptidyl Peptidase-IV |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| DW | Dry Weight |
| EMT | Epithelial–Mesenchymal Transition |
| EO | Essential Oil |
| FRAP | Ferric Reducing Antioxidant Power |
| GABAergic | Gamma-Aminobutyric Acid-ergic (relating to GABA neurotransmission) |
| GAE | Gallic Acid Equivalents |
| GC-MS | Gas Chromatography–Mass Spectrometry |
| GLUT4 | Glucose Transporter Type 4 |
| GPx | Glutathione Peroxidase |
| GR | Glutathione Reductase |
| HDL-C | High-Density Lipoprotein Cholesterol |
| HMG-CoA | 3-Hydroxy-3-Methylglutaryl Coenzyme A |
| HO-1 | Heme Oxygenase-1 |
| HOMA-IR | Homeostatic Model Assessment of Insulin Resistance |
| HPLC-DAD | High-Performance Liquid Chromatography with Diode Array Detection |
| HPV | Human Papillomavirus |
| IC50 | Half Maximal Inhibitory Concentration |
| IL-1α | Interleukin-1 beta |
| IL-6 | Interleukin-6 |
| IVM | Integrated Vector Management |
| LC-MS | Liquid Chromatography-Mass Spectrometry |
| LD50 | Median Lethal Dose |
| LDL-C | Low-Density Lipoprotein Cholesterol |
| LMICs | Low- and Middle-Income Countries |
| LOX | Lipoxygenase |
| LPS | Lipopolysaccharide |
| MDA | Malondialdehyde |
| MeSH | Medical Subject Headings |
| MIC | Minimum Inhibitory Concentration |
| MMP-2 | Matrix Metalloproteinase-2 |
| MMP-9 | Matrix Metalloproteinase-9 |
| MPTP | 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine |
| MRSA | Methicillin-Resistant Staphylococcus aureus |
| NF-kB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NK | Natural Killer (cells) |
| NO | Nitric Oxide |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSAID(s) | Nonsteroidal Anti-Inflammatory Drug(s) |
| PARP | Poly ADP-ribose Polymerase |
| SOD | Superoxide Dismutase |
| T2DM | Type 2 Diabetes Mellitus |
| TBARS | Thiobarbituric Acid-Reactive Substances |
| TNF-alpha | Tumor Necrosis Factor-alpha |
| TPC | Total Phenolic Content |
| TRPV1 | Transient Receptor Potential Vanilloid 1 |
| VEGF | Vascular Endothelial Growth Factor |